Show simple item record

dc.contributor.authorBertsimas, Dimitris
dc.contributor.authorBoussioux, Leonard
dc.contributor.authorCory-Wright, Ryan
dc.contributor.authorDelarue, Arthur
dc.contributor.authorDigalakis, Vassilis
dc.contributor.authorJacquillat, Alexandre
dc.contributor.authorKitane, Driss L.
dc.contributor.authorLukin, Galit
dc.contributor.authorLi, Michael
dc.contributor.authorMingardi, Luca
dc.contributor.authorNohadani, Omid
dc.contributor.authorOrfanoudaki, Agni
dc.contributor.authorPapalexopoulos, Theodore
dc.contributor.authorPaskov, Ivan
dc.contributor.authorPauphilet, Jean
dc.contributor.authorLami, Omar S.
dc.date.accessioned2021-11-01T14:33:42Z
dc.date.available2021-11-01T14:33:42Z
dc.date.issued2021-02-15
dc.identifier.urihttps://hdl.handle.net/1721.1/136840
dc.description.abstractAbstract The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at a steep economic price. We design analytical tools to support these decisions and combat the pandemic. Specifically, we propose a comprehensive data-driven approach to understand the clinical characteristics of COVID-19, predict its mortality, forecast its evolution, and ultimately alleviate its impact. By leveraging cohort-level clinical data, patient-level hospital data, and census-level epidemiological data, we develop an integrated four-step approach, combining descriptive, predictive and prescriptive analytics. First, we aggregate hundreds of clinical studies into the most comprehensive database on COVID-19 to paint a new macroscopic picture of the disease. Second, we build personalized calculators to predict the risk of infection and mortality as a function of demographics, symptoms, comorbidities, and lab values. Third, we develop a novel epidemiological model to project the pandemic’s spread and inform social distancing policies. Fourth, we propose an optimization model to re-allocate ventilators and alleviate shortages. Our results have been used at the clinical level by several hospitals to triage patients, guide care management, plan ICU capacity, and re-distribute ventilators. At the policy level, they are currently supporting safe back-to-work policies at a major institution and vaccine trial location planning at Janssen Pharmaceuticals, and have been integrated into the US Center for Disease Control’s pandemic forecast.en_US
dc.publisherSpringer USen_US
dc.relation.isversionofhttps://doi.org/10.1007/s10729-020-09542-0en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourceSpringer USen_US
dc.titleFrom predictions to prescriptions: A data-driven response to COVID-19en_US
dc.typeArticleen_US
dc.contributor.departmentSloan School of Management
dc.contributor.departmentMassachusetts Institute of Technology. Operations Research Center
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2021-06-29T03:37:51Z
dc.language.rfc3066en
dc.rights.holderThe Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature
dspace.embargo.termsY
dspace.date.submission2021-06-29T03:37:51Z
mit.licenseOPEN_ACCESS_POLICY
mit.metadata.statusAuthority Work and Publication Information Needed


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record